Clinical Trials in Garran, Australian Capital Territory

Find clinical trials in Garran, Australian Capital Territory. Discover local research opportunities and treatment options in your area.

30 Active Trials Found in Garran

Showing 30 trials on this page

Page 1 of 2

Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia

NCT ID: NCT04994717

This clinical trial is studying a new treatment approach for older adults with a type of blood cancer called Philadelphia-negative B-cell precursor acute lymphoblastic leukemia (ALL). The trial com...

Recruiting

Phase: PHASE3 Conditions: Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

NCT ID: NCT06424288

This clinical trial is studying a new treatment for heart failure. Specifically, it aims to find out if a medication called BI 690517, when taken together with empagliflozin, can help improve sympt...

Recruiting

Phase: PHASE3 Conditions: Heart Failure

The AIRTIVITY® Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

NCT ID: NCT06872892

The AIRTIVITY® Study is a clinical trial that aims to find out if a medication called BI 1291583 can help adults with bronchiectasis, a condition that affects the lungs and often leads to coughing ...

Recruiting

Phase: PHASE3 Conditions: Bronchiectasis

A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

NCT ID: NCT07064473

This clinical trial is studying whether a new medicine called vicadrostat, when taken together with an existing diabetes medicine called empagliflozin, can help lower the risk of heart problems in ...

Recruiting

Phase: PHASE3 Conditions: Hypertension, Diabetes Mellitus, Type 2 +1 more

A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT ID: NCT06508658

This clinical trial is studying a new combination treatment for adult patients with diffuse large B-cell lymphoma (DLBCL), a type of aggressive cancer affecting immune cells. Researchers want to se...

Recruiting

Phase: PHASE3 Conditions: Diffuse Large B-Cell Lymphoma

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

NCT ID: NCT04973605

This clinical trial is studying a new treatment called BGB-11417 for patients with relapsed or refractory multiple myeloma, which is a type of blood cancer. The trial has two parts: the first part ...

Recruiting

Phase: PHASE1 Conditions: Relapsed/Refractory Multiple Myeloma

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

NCT ID: NCT06238622

This clinical trial is looking at how well a medication called BI 1015550 works over a longer period for people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). To ...

Recruiting

Phase: PHASE3 Conditions: Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis

The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect

NCT ID: NCT06058585

The CAPTIVATE trial is a large international study looking at different treatments for people with chronic kidney disease (CKD). The main goal of this trial is to find the best way to slow down the...

Recruiting

Phase: PHASE3 Conditions: Chronic Kidney Diseases

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

NCT ID: NCT06722235

This clinical trial is studying a medication called mezagitamab to see if it can help adults with chronic primary immune thrombocytopenia (ITP). ITP is a condition where the immune system mistakenl...

Recruiting

Phase: PHASE3 Conditions: Immune Thrombocytopenic Purpura (ITP)

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

NCT ID: NCT05636176

This clinical trial is studying a new treatment called ziltivekimab for people with heart failure who also have inflammation. Heart failure means the heart isn't pumping blood as well as it should,...

Recruiting

Phase: PHASE3 Conditions: Heart Failure

A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation

NCT ID: NCT06200207

This clinical trial is studying a new medicine called ziltivekimab to see how well it works for people with heart failure and inflammation. Participants in the study will either receive ziltivekima...

Recruiting

Phase: PHASE3 Conditions: Heart Failure, Systemic Inflammation

Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

NCT ID: NCT06236438

This clinical trial is studying a new treatment approach for adults with untreated metastatic non-squamous non-small cell lung cancer (NSCLC), which is a serious type of lung cancer. Researchers wa...

Recruiting

Phase: PHASE2 Conditions: Non-Small Cell Lung Cancer

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

NCT ID: NCT06128629

The MAGNITUDE trial is a Phase 3 study that is looking at a new treatment called NTLA-2001 for people with a condition called transthyretin amyloidosis with cardiomyopathy (ATTR-CM), which affects ...

Recruiting

Phase: PHASE3 Conditions: Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study

NCT ID: NCT06290505

The PALEO Study is a clinical trial looking at new treatment options for people with esophageal cancer that is either locally advanced or has spread to other parts of the body. This trial aims to f...

Recruiting

Phase: PHASE2 Conditions: Esophageal Cancer

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

NCT ID: NCT06383390

The TRIUMPH-OUTCOMES study is looking at a new treatment called retatrutide, which is given once a week, to see if it can help reduce serious heart problems and protect kidney function in adults wh...

Recruiting

Phase: PHASE3 Conditions: Chronic Kidney Disease (CKD), Atherosclerotic Cardiovascular Disease (ASCVD)

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Perioperative AF After Noncardiac Surgery

NCT ID: NCT03968393

This clinical trial is looking at whether taking blood-thinning medication (called anticoagulants) can help prevent strokes in patients who have experienced temporary atrial fibrillation (AF) after...

Recruiting

Phase: PHASE4 Conditions: Stroke, Atrial Fibrillation

Observational Study Protocol: LIVER-R

NCT ID: NCT06252753

The LIVER-R study is a clinical trial aimed at understanding how effective a treatment called durvalumab is for patients with certain types of liver and bile duct cancers. This study will gather in...

Recruiting

Conditions: Hepatobiliary Cancers

Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction

NCT ID: NCT05651347

This clinical trial is investigating whether melatonin, a natural hormone, can help protect the brain of babies who are not growing properly in the womb, a condition known as fetal growth restricti...

Recruiting

Phase: PHASE3 Conditions: Fetal Growth Retardation, Pregnancy Preterm +1 more

Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain

NCT ID: NCT04662905

This clinical trial is studying a new way to deliver treatment for chronic pain using a specialized device called the Evoke System. The trial aims to evaluate a closed-loop system that automaticall...

Recruiting

Phase: NA Conditions: Chronic Pain

Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial

NCT ID: NCT05334368

This clinical trial is studying a new treatment called depemokimab for adults with Hypereosinophilic Syndrome (HES), a condition where the body produces too many eosinophils, a type of white blood ...

Recruiting

Phase: PHASE3 Conditions: Hypereosinophilic Syndrome